Status:
COMPLETED
Aromatherapy for Chemotherapy-induced Nausea and Vomiting (CINV)
Lead Sponsor:
University of Miami
Conditions:
Chemotherapy-induced Nausea and Vomiting
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to evaluate the use of aromatherapy to reduce nausea, vomiting, and the use of anti-emetic in cancer survivors undergoing moderate to highly emetogenic chemotherapy regime...
Eligibility Criteria
Inclusion
- 18 years of age or older
- Able to read and speak English or Spanish
- Able to and willing to give informed consent
- Currently undergoing moderate and high emetogenic chemotherapy (adjuvant or neoadjuvant)
- Receiving three or more remaining cycles of chemotherapy
- Symptoms of nausea or vomiting after the first chemotherapy infusion
Exclusion
- Unable or unwilling to give informed consent
- Sensitivity to essential oils\*
- Olfactory disorders
- Receiving chemotherapy for the first time
- Undergoing low emetogenic chemotherapy regimens
- Patients with hormone-sensitive cancers
- Timely request of treating provider
Key Trial Info
Start Date :
August 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 15 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05319860
Start Date
August 1 2022
End Date
April 15 2024
Last Update
April 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Miami
Miami, Florida, United States, 33136